Acarbose best suited for newly diagnosed type 2 diabetes patients with obesity Dr Kartikeya Kohli2 Nov 2022 12:00 PM ISTChina: Acarbose is the first glucosidase inhibitor used in the clinical therapy of type 2 diabetes mellitus (T2DM). The mode of action is that it may...
Consumption of fruits as last meal reduces fasting blood sugar independent of DPP4 activity Roshni Dhar31 Oct 2022 5:45 PM IST A randomized pilot study published in the Journal of Obesity has shown the effects of the combination of a fruit-carbohydrate meal sequence and...
Health Bulletin 31/October/2022 Roshni Dhar31 Oct 2022 4:49 PM ISTHere are the top health stories for the day:Alleged failure in diagnosing Microcephaly: Max Hospital, Doctor absolved of medical negligence chargesThe...
Downs syndrome patients four times more likely to develop type 2 diabetes Dr.Niharika Harsha B17 Oct 2022 8:00 PM ISTA recent study found that young Downs syndrome patients have four times more incidence of type 2 diabetes than controls due to higher body mass index....
Male Diabetics with infective endocarditis have lower in-hospital mortality compared to females Dr.Niharika Harsha B17 Oct 2022 7:30 PM ISTA recent study found that Type 2 diabetic male patients had a higher incidence of infective endocarditis and lower rates of in-hospital mortality than...
Affordable Sitagliptin, Sitagliptin- Metformin combination to be available at Janaushadhi Kendras Dr. Nandita Mohan20 Sept 2022 11:18 AM ISTChief Executive Officer of Pharmaceuticals & Medical Devices Bureau of India (PMBI) Shri Ravi Dadhich has launched Sitagliptin a new variant of...
Health Bulletin 19/September/2022 Dr. Nandita Mohan19 Sept 2022 5:40 PM ISTHere are the top health news for the day:NCDRC exonerates Cardiologist, Hospital of Negligence in implating pacemaker The National Consumer Disputes...
Sitagliptin, Sitagliptin- Metformin combination to be available at Janaushadhi Kendras at price range of Rs 60 - Rs 100 per pack Ruchika Sharma18 Sept 2022 5:00 PM ISTSitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SGLT2I has an edge over DPP4I in lowering risk of NAFLD, and HCC among diabetes patients Dr.Niharika Harsha B5 Sept 2022 12:00 PM ISTSodium-glucose cotransporter 2 inhibitors (SGLT2I) have a low risk of non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (HCC) in...
Preadmission insulin-treated diabetes patients more likely to die in ICUs: Study Medha Baranwal14 Aug 2022 8:00 PM ISTChina: Among type 2 diabetes (T2DM) patients in ICU, preadmission insulin treatment is associated with a longer length of ICU stay and an increased...
Once Daily Vildagliptin 100 mg sustained-release therapeutically safe, effective as Vildagliptin 50 mg twice daily add on to Metformin in Indian Diabetics Lalhmangaihkimi12 Aug 2022 12:30 PM ISTVildagliptin 100 mg sustained-release once daily is therapeutically safe and effective as Vildagliptin 50 mg tablet twice daily as an add-on to...
Zydus Lifesciences bags USFDA approval for Empagliflozin, Metformin Hydrochloride Tablets Ruchika Sharma11 July 2022 12:23 PM ISTThe drug will be manufactured at the group’s formulation facility at SEZ, Ahmedabad, India.
